Parnax Lab (506128.BO) Hisse Fiyat

Parnax Lab Ltd. engages in manufacturing and trading of pharmaceuticals and medicinal products. The company is headquartered in Mumbai, Maharashtra and currently employs 12 full-time employees. The company went IPO on 2009-09-15. The firm is principally engaged in the business activities of manufacturing and export of pharmaceutical formulations. The company is also focused on the trading of pharmaceuticals and medicinal products. The firm operates through dealing in the pharmaceutical formulations segment. The company is engaged in developing and delivering huge volumes of oral formulations, such as cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, special formulations for geriatrics, highly viscous products, suspensions and others. The Company’s subsidiary is Naxpar Pharma Private Limited.